Risk factors for survival following combined heart‐lung transplantation: The first 100 patients

Transplantation

Volumn 57, Issue 2, 1994, Pages 218-223

  Sharples, Linda D ^a   Scott, John P ^b   Dennis, Christopher ^c   Higenbottam, Timothy W ^c   Stewart, Susan ^c   Wreghitt, Timothy ^d   Large, Stephen R ^c   Wells, Frank C ^c   Wallwork, John ^c  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

^b MAYO CLINIC   (United States)

^c PAPWORTH HOSPITAL   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CARDIOPULMONARY BYPASS; CHILD; DEATH; FEMALE; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTUBATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SURVIVAL;

ACTUARIAL ANALYSIS; ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMAN; MALE; MIDDLE AGE; RISK FACTORS;

EID: 0028012871     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199401001-00011     Document Type: Article

References (26)

1. Pasque MK, Kaiser LR, Dresler CM, Trulock E, Triantafillou AN, Cooper JD. Single lung transplantation for pulmonary hypertension: technical aspects and immediate hemodynamic results. J Thorac Cardiovasc Surg 1992; 103: 475.
2. McCarthy PM, Rosenkrantz ER, White RD, et al. Single lung transplantation with atrial septal defect repair for Eisen-menger’s syndrome. Ann Thorac Surg 1991; 52: 300.
3. Khaghani A, Banner N, Ozdogan E, et al. Medium-term results of combined heart and lung transplantation for emphysema. J Heart Lung Transplant 1991; 10: 15.
4. Emery RW, Graif JL, Hale K, et al. Treatment of end-stage chronic obstructive pulmonary disease with double lung transplantation. Chest 1991; 99: 533.
5. Smyth RL, Higenbottam T, Scott J, Wallwork J. The current state of lung transplantation for cystic fibrosis. Thorax 1991; 46: 213.
6. Lewiston N, Starnes V, Theodore J. Heart lung and lung trans plantation for cystic fibrosis. Clin Rev Allergy 1991; 9: 231.
7. Madden BP, Hodson ME, Tsang V, Radley-Smith R, Khaghani A, Yacoub MY. Intermediate results of heart-lung transplantation for cystic fibrosis. Lancet 1992; 339: 1583.
8. Whitehead B, Helms P, Goodwin M, et al. Heart-lung transplan tation for cystic fibrosis: II. Outcome. Arch Dis Child 1991; 66:1022.
9. Michler RE, Rose EA. Pediatric heart and heart lung transplan tation. Ann Thorac Surg 1991; 52: 708.
10. Starnes VA, Marshall SE, Lewiston NJ, Theodore J, Stinson EB, Shumway NE. Heart lung transplantation in infants, children, and adolescents. J Pediatr Surg 1991; 26: 434.
11. Starnes VA, Oyer PE, Bernstein D, et al. Heart, heart-lung and lung transplantation in the first year of life. Ann Thorac Surg 1992; 53: 306.
12. Kaye MP. The Registry of the International Society for Heart and Lung Transplantation: ninth official report 1992. J Heart Lung Transplant 1992; 11: 599.
13. Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990; 11: 291.
14. Villemot JP, Busson M. Heart-lung transplantation: causes of failure in the first postoperative month. Presse Med 1991; 20: 1979.
15. Novick RJ, Menkis AH, McKenzie FN, Reid KR, Ahmad D.Should heart lung transplant donors and recipients be matched according to cytomegalovirus serologic status? J Heart Transplant 1990; 9: 699.
16. Scott JP, Higenbottam TW, Clelland CA, et al. Natural history of chronic rejection in heart lung transplant recipients. J Heart Transplant 1990; 9: 510.
17. Theodore J, Starnes VA, Lewiston NJ. Obliterative bronchiolitis.Clin Chest Med 1990; 11: 309.
18. Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus sero logic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51: 433.
19. Scott JP, Higenbottam TW, Sharpies L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51: 813.
20. Yousem SA, Dauber JA, Keenan R, Paradis IL, Zeevi A, Griffith BP. Does histological acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1991; 52: 306.
21. Hutter JA, Despins P, Higenbottam T, Stewart S, Wallwork J.Heart-lung transplantation: better use of resources. Am J Med 1988; 85: 4.
22. Gray JJ, Alvey B, Smith DJ, Wreghitt TG. Evaluation of a com mercial latex agglutination test for detecting antibodies to cytomegalovirus in organ donors and transplant recipients. J Virol Methods 1987; 16: 13.
23. Hill AB. A short textbook of medical statistics, 11th ed. London:Hodder and Stoughton, 1984.
24. Breslow NE, Day NE. Methods in cancer research, vol 1: The analysis of case-control studies. Lyon: International Agency for Research on Cancer Scientific (Publ. 32), 1980.
25. Cox DR. Regression models and life tables. J R Statis Soc B 1972;34: 187.
26. Peck DF, Shapiro CM, eds. Measuring human problems: a prac tical guide. Chichester: Wiley, 1990.